David C Sogin

**Title: David C. Sogin – Innovator in Immunoassay Technology**

Introduction

David C. Sogin, an accomplished inventor based in Highland Park, IL, has made noteworthy contributions in the field of immunoassay technology. With a patent to his name, he has demonstrated a strong commitment to advancing medical diagnostics and enhancing understanding of human health.

Latest Patents

David's patent, titled "PlGF-1 assay and kits and components thereof," delves into glycosylated and deglycosylated human PlGF-1. This innovative work covers various aspects, including methods of employing both forms of human PlGF-1 and the antibodies that bind to it. Furthermore, his patent outlines methods for utilizing these antibodies and the development of human PlGF-1 immunoassays and related kits, providing valuable tools for researchers and clinicians alike.

Career Highlights

Working at Abbott Laboratories Corporation, David C. Sogin has established himself as a key player in the development of life-enhancing medical technologies. His work aligns with the mission of Abbott Laboratories, a global leader in healthcare, committed to delivering innovative solutions that improve patient care and health outcomes.

Collaborations

In his professional journey, David has collaborated with notable peers, including Susan E. Brophy and Lianli Chi. Their collective expertise and insights enhance the innovative capacity of their projects, fostering an environment of creativity and advancement within the laboratory.

Conclusion

David C. Sogin's dedication to innovation in the field of immunoassay technology, alongside his valuable collaboration with talented colleagues, highlights his impact on healthcare. As he continues to develop his expertise, his contributions are sure to pave the way for future advancements in medical diagnostics.